LYON, France, March 3, 2026 /PRNewswire/ — Efor, a global leader specializing in quality and compliance for the Life Sciences industry, announces the acquisition of Singapore-based No deviation, a company recognized for its expertise in Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), Quality Compliance and Digital Enablement.
Founded in 2013, Efor has built a leading international platform dedicated to quality and compliance for Life Sciences industries. With more than 3,000 professionals operating across 18 countries, the group supports global pharmaceutical, biotechnology and medical device leaders.
This operation represents a significant milestone in Efor’s continued expansion across Asia. With more than 300 professionals now operating in the region, Efor reaches a new level of scale and strengthens its position within the Asian market.
Founded in 2007, No deviation operates today in Singapore, China and Ireland, with Singapore serving as its primary hub.
With an established presence across key Asian Life Sciences markets, No deviation has developed strong local execution capabilities, particularly in fast-growing biopharmaceutical environments.
The alliance builds on a shared vision of delivering high-value quality and compliance solutions across complex industrial projects.
By bringing No deviation into the group, Efor significantly strengthens its regional capabilities in Commissioning, Qualification & Validation (CQV) and high-standard complianceservices.
This acquisition further reinforces Efor’s global expansion strategy, combining sustained organic growth with targeted acquisitions.
“Asia is a strategic pillar of our global vision. With No deviation, we are strengthening our presence and positioning Efor as a leading quality and compliance playeracross key Asian markets,” said Mathieu Roger, Founder and President of Efor.
“Joining Efor opens a new chapter for No Deviation. This partnership expands our reach while preserving the technical depth and entrepreneurial spirit that define our organization,” said Pierre Winnepenninckx, Founder of No deviation.
Logo – https://mma.prnewswire.com/media/2922502/Efor_Logo.jpg
Contact : Floriane CARRET – floriane.carret@efor-group.com
View original content:https://www.prnewswire.co.uk/news-releases/efor-strengthens-its-presence-in-asia-with-the-acquisition-of-no-deviation-302699944.html
YEREVAN, Armenia, June 1, 2026 /PRNewswire/ -- Armen Pogossian, Owner of Pogossian Luxury Brand House,…
Six months after its strategic investment, Firstsource announces proven outcomes from live deployments in healthcare…
The Korean skincare brand debuts a global campaign, built around the PDRN Collagen Glow Facial Serum…
News Summary:Relativity FOIA, a legal data intelligence solution for public disclosure operations, is now generally…
Debuting in the U.S. June 1, with international availability this fall ROCHESTER, N.Y., June 1,…
>10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle…